close
MENU
Hot Topic Hawke’s Bay
Hot Topic Hawke’s Bay
3 mins to read

LanzaTech narrows loss to $34.7m, shifting into commercialisation phase

The company reported a loss of $34.7 million in calendar 2014.

Fiona Rotherham
Wed, 08 Jul 2015

LanzaTech New Zealand, the NZ-founded carbon recycling company, narrowed its annual loss as the company shifts into commercialisation from its previous development phase.

The company reported a loss of $34.7 million in calendar 2014, smaller than the loss of $40.5 million a year earlier, according to financial statements lodged with the Companies Office. Including $2.8 million of exchange differences on foreign operations lifts the total comprehensive loss to $37.5 million. 

Revenue rose to $8.5 million in 2014 from $5.7 million a year earlier, with $6.58 million derived from commercial contracts and the other $1.92 million from government deals.

LanzaTech turns waste gas from steel mills into ethanol and other high-value fuels and chemicals, and announced last year it had teamed with Indian researchers to develop a way to use carbon dioxide emissions to produce omega-3 rich fatty acids, using the firm’s unique microbial process.

Earlier this year, the company said it had other full-scale commercial plants in the pipeline following a decision by China Steel Corp to invest $US46 million in a commercial-scale ethanol facility in Taiwan, using steel mill gases for ethanol production.  Construction is due to start on the new 50 metric tonne facility in the last quarter of this year and LanzaTech said other pilots likely to be scaled up include one with BaoSteel in China.

LanzaTech was founded 10 years ago in New Zealand and the parent company remains in this country while headquarters have been shifted to the US. Last month it appointed Jean Paul Michel, the former chief operating officer at lighting company OSRAM, as executive vice president strategy, finance and operations to lead a new team coordinating the company’s core support functions as it enters the commercialisation phase.

In the annual accounts filed today, the group reported net operating cash outflow for the 2014 year of $30.5 million. LanzaTech owed $10.3 million in outstanding third party loans while holding $109 million in cash and cash equivalents at the end of December following further capital raising during the year.

The company has so far raised more than $US200 million from investors including $US60 million from the NZ Superannuation Fund last December, which became the second largest shareholder after Silicon Valley-based Kholsa Ventures.

Directors said the group had experienced and is expected to continue to experience net losses from operations for the foreseeable future. However, they considered “the continued adoption of the going concern basis is appropriate based on a reasonable expectation that there will be sufficient funds to enable the group to continue operations at existing levels for the foreseeable future” and for the next year at least.

As at the end of 2014, the group and parent had $92 million and $40 million respectively of unrecognised tax losses.

During the year the New Zealand parent transferred $3.3 million worth of property and equipment to its American subsidiary, LanzaTech, Inc and research and development facility, the Freedom Pines Biorefinery, at the net book value of the assets.

As at December 31 the company was involved in legal proceedings in the US relating to a claim against it for $US526,000 plus interests and plaintiff’s costs, for an alleged broker commission owed by LanzaTech to the plaintiff in relation to its lease agreement for new premises in Skokie, Illinois.

LanzaTech has argued no commission is payable as claimed, is “vigorously contesting” the allegations, and has filed a counterclaim and third party claim against an affiliate of the plaintiff. At this stage, the company said it couldn't estimate the likelihood or amount of any potential loss, if any, from the suit and has not accrued for any potential exposure in its accounts. 

(BusinessDesk)

BusinessDesk receives funding to help cover the commercialisation of innovation from Callaghan Innovation.

Fiona Rotherham
Wed, 08 Jul 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
LanzaTech narrows loss to $34.7m, shifting into commercialisation phase
49383
false